In The News

Ropes & Gray Advises Sarepta Therapeutics in $313.5 Million Convertible Senior Notes Exchange

Practices: Capital Markets, Securities & Public Companies, Finance Industries: Healthcare & Life Sciences

Ropes & Gray advised Sarepta Therapeutics, Inc. in separate, privately negotiated exchange agreements with certain holders of its 1.50% Convertible Senior Notes due 2024. Under the terms of the Exchange Agreements, the holders have agreed to exchange with Sarepta approximately $313.5 million in aggregate principal amount of Notes held by them for approximately 4.5 million shares of the company’s common stock. Goldman Sachs and J. Wood Capital Advisors LLC. acted as exchange agents.

The Ropes & Gray team was led by capital markets partner Daniel Forman and capital markets associates Dayna Atkins and Caroline Lawrence.

Cookie Settings